[ad_1]
“The first agreement in Europe has been signed between the Russian government fund and ADIENNE Pharma & Biotech for the production of the Sputnik V vaccine in Italy.” This was announced by the Italian-Russian Chamber of Commerce in a note published on its website. In the last hours, the CEO of the Russian Direct Investment Fund (RDIF), Kirill Dmitriev, confirmed that he has reached an agreement with the company ADIENNE Pharma & Biotech for the production of Sputnik V in Italy, signing the first European contract for the production of local vaccine. “The vaccine will be produced from July at the Adienne headquarters in Caponago, near Monza. But the Lombardy Region makes it known with a note that it has learned” from the press reports of an agreement between Adienne Pharma Biotech and the Russian government fund Russian Direct Investment Fund for the production of the Sputnik vaccine in Italy. The Lombardy Region underlines its strangeness with respect to the aforementioned agreement, of which it only became aware of indirectly through the media. This agreement is in fact exclusively of private law profile between the contracting parties.
Sputnik, the vaccine you like. This is what we really know
by Elena Dusi
“Sputnik’s innovative” production process will help create new jobs and allow Italy to control the entire production process of the preparation. This will allow the production of 10 million doses before the end of the year, “he says. the Italo-Russian Chamber of Commerce, in the note.
Vaccines, Europe opens in Sputnik. Ema begins the review. Moscow: “Since June 50 million doses”
by Elena Dusi
The meetings that led to the agreement began in October with the aim of identifying some strategic partners to prepare production in the Italian territory. The biopharmaceutical company Adienne Pharma & Biotech, chaired by Antonio Francesco Di Naro, was founded in 2004 and, over the years, has specialized in the production of niche medicines, often ignored by large productions, to treat the called rare or orphan diseases. In particular in the research and commercialization of oncohematology, autoimmune diseases, transplantation of organs and bone marrow. For his productions he has also received several awards.
Kremlin spokesman Dmitry Peskov said Italian production of Sputnik V will help meet demand for doses abroad.
First dose of vaccine to the largest possible number of people: Bertolaso’s plan against the emergency
by Zita Dazzi
Russian Sputnik vaccine, Moratti asks Arcuri to use it. Airports, Palalido and Fiera for injections
by Andrea Montanari
